Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Testing effectiveness (Phase 2)UnknownNCT01221376
What this trial is testing

Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+)

Who this might be right for
Chronic Myeloid Leukemia (CML) With Philadelphia Chromosome-positive (Ph+)
Renato Melaragno 20
Early research (Phase 1)Study completedNCT01569750
What this trial is testing

A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma

Who this might be right for
CD20-positive B-cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLC 33
Testing effectiveness (Phase 2)Study completedNCT01275859
What this trial is testing

Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Asan Medical Center 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03377387
What this trial is testing

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 34
Early research (Phase 1)Study completedNCT04572295
What this trial is testing

E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Eisai Co., Ltd. 51
Testing effectiveness (Phase 2)Study completedNCT03357757
What this trial is testing

Avelumab With Valproic Acid in Virus-associated Cancer

Who this might be right for
Cancer That is Associated With a Chronic Viral Infectionp16 Positive SCCHNSquamous Cell Carcinoma of the Cervix+5 more
AHS Cancer Control Alberta 39
Not applicableLooking for participantsNCT05735444
What this trial is testing

Prospective National Multi-center Registry of Obstructive Sleep Apnea Syndrome in Hypertensive Patients in China

Who this might be right for
HypertensionObstructive Sleep Apnea
Shanghai Jiao Tong University School of Medicine 633
Testing effectiveness (Phase 2)Active Not RecruitingNCT04086264
What this trial is testing

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
AbbVie 218
Not applicableStudy completedNCT02984709
What this trial is testing

Check It! 2.0: Positive Psychology Intervention for Adolescents With Type 1 Diabetes

Who this might be right for
Type1diabetes
Vanderbilt University 48
Early research (Phase 1)Study completedNCT00372424
What this trial is testing

Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive

Who this might be right for
Breast Cancer
Pfizer 26
Not applicableNot Yet RecruitingNCT07183124
What this trial is testing

3D Modeling for Detecting Locally Advanced Rectal Cancer With Positive Circumferential Resection Margin

Who this might be right for
General SurgeryOncologyMedical Informatics
Taichung Veterans General Hospital 1,500
Not applicableStudy completedNCT02245659
What this trial is testing

Effect of CPAP Treatment on Glycemic Control in Gestational Diabetes: A Pilot Randomized-Controlled Trial

Who this might be right for
PregnancySleep-disordered BreathingGestational Diabetes
McGill University Health Centre/Research Institute of the McGill University Health Centre 46
Not applicableWithdrawnNCT03277742
What this trial is testing

Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz

Who this might be right for
Pulmonary TuberculosisDiabetes Mellitus, Type 2
Instituto Nacional de Salud Publica, Mexico
Early research (Phase 1)Ended earlyNCT03927573
What this trial is testing

Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker

Who this might be right for
Non-small Cell Lung CancerProstate CancerRenal Cancer+1 more
AvenCell Europe GmbH 23
Not applicableStudy completedNCT07502469
What this trial is testing

Study Comparing the Contribution of G-Eye Combined With CAD-Eye Versus High-definition Colonoscopy With CAD-Eye in the Detection of Colonic Lesions After a Positive Immunological Test in the Context of Organized Colorectal Cancer (BENEFIT)

Who this might be right for
Colorectal CancerColo-rectal Cancer
Elsan 341
Early research (Phase 1)Looking for participantsNCT05857969
What this trial is testing

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+15 more
Florida International University 65
Not applicableStudy completedNCT02682069
What this trial is testing

Positive Predictive Value of the MolecuLight i:X Imaging Device to Predict the Presence of Bacteria in Chronic Wounds

Who this might be right for
Wounds
MolecuLight Inc. 30
Testing effectiveness (Phase 2)Study completedNCT03535740
What this trial is testing

Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib

Who this might be right for
ALK-positive Advanced NSCLC
Ariad Pharmaceuticals 103
Large-scale testing (Phase 3)UnknownNCT02668718
What this trial is testing

Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Helsinki University Central Hospital 250
Next Page